Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsScientists focus on the use of engineered cells to treat glioblastoma, with an emphasis on data from the small number of clinical trials that have been performed to date and the lessons learned from these.
[Cancer Gene Therapy]
6807162 {6807162:ZR9MT6I9} apa 50 1 160427 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-094d1ae406f5dc5034b4e7041f0cc2d4%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22ZR9MT6I9%22%2C%22library%22%3A%7B%22id%22%3A6807162%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ramanathan%20and%20Lorimer%22%2C%22parsedDate%22%3A%222021-03-22%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ERamanathan%2C%20A.%2C%20%26amp%3B%20Lorimer%2C%20I.%20A.%20J.%20%282021%29.%20Engineered%20cells%20as%20glioblastoma%20therapeutics.%20%3Ci%3ECancer%20Gene%20Therapy%3C%5C%2Fi%3E%2C%201%26%23x2013%3B11.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41417-021-00320-w%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41417-021-00320-w%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6807162%26amp%3Bitem_key%3DZR9MT6I9%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Engineered%20cells%20as%20glioblastoma%20therapeutics%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aparna%22%2C%22lastName%22%3A%22Ramanathan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%20A.%20J.%22%2C%22lastName%22%3A%22Lorimer%22%7D%5D%2C%22abstractNote%22%3A%22In%20spite%20of%20significant%20recent%20advances%20in%20our%20understanding%20of%20the%20genetics%20and%20cell%20biology%20of%20glioblastoma%2C%20to%20date%2C%20this%20has%20not%20led%20to%20improved%20treatments%20for%20this%20cancer.%20In%20addition%20to%20small%20molecule%2C%20antibody%2C%20and%20engineered%20virus%20approaches%2C%20engineered%20cells%20are%20also%20being%20explored%20as%20glioblastoma%20therapeutics.%20This%20includes%20CAR-T%20cells%2C%20CAR-NK%20cells%2C%20as%20well%20as%20engineered%20neural%20stem%20cells%20and%20mesenchymal%20stem%20cells.%20Here%20we%20review%20the%20state%20of%20this%20field%2C%20starting%20with%20clinical%20trial%20studies.%20These%20have%20established%20the%20feasibility%20and%20safety%20of%20engineered%20cell%20therapies%20for%20glioblastoma%20and%20show%20some%20evidence%20for%20activity.%20Next%2C%20we%20review%20the%20preclinical%20literature%20and%20compare%20the%20strengths%20and%20weaknesses%20of%20various%20starting%20cell%20types%20for%20engineered%20cell%20therapies.%20Finally%2C%20we%20discuss%20future%20directions%20for%20this%20nascent%20but%20promising%20modality%20for%20glioblastoma%20therapy.%22%2C%22date%22%3A%222021-03-22%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41417-021-00320-w%22%2C%22ISSN%22%3A%221476-5500%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41417-021-00320-w%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-03-23T20%3A00%3A22Z%22%7D%7D%5D%7D
Ramanathan, A., & Lorimer, I. A. J. (2021). Engineered cells as glioblastoma therapeutics. Cancer Gene Therapy, 1–11. https://doi.org/10.1038/s41417-021-00320-w Cite
